https://european-biotechnology.net/wp-content/uploads/2025/10/ESMO-e1761055975736-1030x581-1.jpg5811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-21 14:13:192025-10-21 14:13:19Tubulis presents first clinical data on ADC TUB-040
https://european-biotechnology.net/wp-content/uploads/2025/10/Merck.jpg470840Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-17 12:57:312025-10-17 12:57:31Merck KGaA reduces US prices for IVF drugs by 84%
https://european-biotechnology.net/wp-content/uploads/2025/10/Adcytherix_Jack_Elands_CEO_tg-scaled-e1760595632424-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-16 09:03:442025-10-16 09:03:44ADC specialist Adcytherix SAS raises €105m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/10/tubulis_linker_ADC_web.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-15 09:08:402025-10-15 09:08:40Tubulis secures €308m in record-breaking Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/Mianzbiomed-47-1-e1760519293304-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-12 09:08:372025-10-12 09:08:37Blood test detects pancreatic cancer early
https://european-biotechnology.net/wp-content/uploads/2025/10/cq5dam.web_.1200.Jon-picture-cropped-2-1030x510-1.jpg5101030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-11 09:34:022025-10-11 09:34:02AstraZeneca agrees to MFN price reductions with US government
https://european-biotechnology.net/wp-content/uploads/2025/10/Ersatzbild_PSX_20251007_100334-e1759837974415-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-07 08:37:572025-10-10 11:02:03BioSpain 2025 starts with new records
